Χριστίνα Χρυσοχόου Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών

Size: px
Start display at page:

Download "Χριστίνα Χρυσοχόου Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών"

Transcription

1 Ιωάννης Ανδρέου Χριστίνα Χρυσοχόου Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών Ιπποκράτειο Γ.Ν.Α

2 Splenectomy at the age of 7yrs Episodes of persistent atrial fibrillation Hypothyroidism Osteoporosis Noncompliant with longterm deferoxamine chelation 44yearold man suffering from βthalassemiamajor diagnosed at the age of 1yr Despite optimal medical treatment with enalapril, carvedilol, furosemideand spironolactone, the patient experienced progressive severe dyspnea, with symptoms caused by minimal activities (NYHA Class III IV) Last year multiple admissions for acute decompensations

3 Physical examination jaundice poor musculature hepatomegaly leg ulcers skeletal changes resulting from expansion of the bone marrow The jugular veins were palpable and dilated dilated abdomen with diffuse tenderness, ascitesand liver enlargement The arterial pressure was 90/60 mmhg The chest roentgenogram revealed increased cardiothoracic ratio and right lung pleural effusion Electrocardiogram sinus rhythm, RBBB

4

5

6

7 Echocardiography

8 Echocardiography

9 Apical 4 chamber view

10

11

12 Magnetic resonance imaging of the heart showed a very low T2* value, consistent with a relevant myocardial iron overload

13 Assessment of Iron Overload with T2* Magnetic Resonance Imaging Method of choice for tissue iron assessment T2* is a magnetic relaxation property of any tissue and is inversely related to intracellular iron stores

14 2005

15 Epidemiology Genetics βthalassemiais caused by the reduced or absent synthesis of the beta globinchainsof the hemoglobin tetramer 3 clinical and hematological conditions of increasing severity are recognized thalassemiaminor betathalassemiacarrier state (results from heterozygosity for betathalassemia) thalassemiaintermedia (heterogeneous group of thalassemialike disorders) thalassemia major (severe transfusiondependent anemia)

16 5000 pts with βthalassemia in Greece

17 The life of patients with thalassemia has improved both in duration and in quality in industrialized countries Complications are still common and include heart disease (heart failure and arrhythmias) chronic liver hepatitis, which can evolve in cirrhosis and, rarely, in hepatocellular carcinoma endocrine problems (hypogonadism, hypothyroidism, diabetes, hypoparathyr oidism) stunted growth osteoporosis thrombophilia Higgs DR et al. Lancet 2012;379:373*83

18 βthalassemiamajor major mid1960s : only 37% survival at the age of 16 years 2004 : a 83% survival rate beyond 40 years oral iron chelators deferipronein 2000 deferasirox in 2007 Kremastinos DT et al. Circ Heart Fail 2010;3:451458

19 βthalassemia Cardiomyopathy Cardiac complications are the cause of the deaths in 7080% of the patients with β thalassemia major Cardiac failure and serious arrhythmias are the major causes of lifethreatening morbidity and mortality in ironoverload patients βthalassemiapatients are susceptible to benign pericarditis, possibly caused by viral and mycoplasmal organisms, bacterial or fungal infections Ginzburg Y, Rivella S Blood 2011;118:432130

20 βthalassemia Cardiomyopathy (i) a dilated cardiomyopathy phenotype characterized by left ventricular dilatation and reduced contractility, leading to congestive heart failure; (ii) a restrictive cardiomyopathy phenotype characterized by restrictive left ventricular filling with subsequent pulmonary hypertension, right ventricular dilatation, and heart failure. (iii) mixed type HF Myocardial iron depositionin some patients with thalassemiamajor may not directly affect left ventricular contractility, but it may rather cause left ventricular myocardial restriction Kremastinos DT et al. Circ Heart Fail 2010;3:451*458

21 Pathophysiology Before the introduction of regular blood transfusions, patients developed a form of highoutput heart failure In the era of systematic transfusion therapy, myocardial iron overload is traditionally thought to be the main cause of thalassemia cardiomyopathy its main cause is the repetitive blood transfusions ineffective erythropoiesis peripheral hemolysis increased intestinal iron absorption Iron toxicity has been attributed to the production of free oxygen radicals Higgs DR et al. Lancet 2012;379:37383

22 Pathophysiology Myocarditisalso seems to play a role in the pathogenesis of cardiomyopathyin patients with thalassemia The role of viral infections seems to be of particular relevance in patients with thalassemiabecause of their repetitive exposure to a significant, transfusion associated viral burden The role of immunogeneticmechanisms in the pathogenesis of thalassemiacardiomyopathyhas been stressed by the reported differences in human leukocyte antigen profile between patients with thalassemiawith and without heart failure Kremastinos DT et al. Circ Heart Fail 2010;3:451458

23 Management Thalassemia patients respond poorly to the usual pharmacological treatment with ACEinhibitors, beta blockers and diuretics. The recent introduction of dual ironchelation therapy, by combining the traditional parenteral chelator deferoxamine with the newer oral one deferiprone seems to enhance the efficacy of treatment. Patients with overt heart failure (moderate to severe) and marked myocardial iron overload tend to be less responsive to intensive chelation Ginzburg Y, Rivella S Blood 2011;118:432130

24 Management 1. Regular longlife red blood cell transfusions 2. Iron chelation therapy to remove iron introduced in excess with transfusions The only definitive cure is bone marrow transplantation Therapies under investigation are the induction of fetal hemoglobin with pharmacologic compounds and stem cell gene therapy. Ginzburg Y, Rivella S Blood 2011;118:432130

25

26 Myocardial iron is hard to measure Serum ferritinconcentration, useful but rather rough estimate of total body iron load (Ferritin levels less than 2,500 ng/ml are associated with improved survival. However, ferritin levels are unreliable when liver disease is present) Olivieri NF et al. N Engl J Med 1994;331:574-8 Cardiovascular MRI allows an accurate assessment of iron (T2* imaging) provides a precise quantification of myocardial and hepatic iron load and has become a useful tool for the evaluation of patients and for the therapeutic guidance and follow-up of iron chelation therapy Kirk P et al. Circulation 2009;120:1961-8

27 Cardiac function is monitored annually beginning at Cardiac function is monitored annually beginning at 7 or 8 years of age by electrocardiogram, echocardiogram, 24hour Holter monitor, and recently by cardiac T2* MRI, which can detect preclinical cardiac iron accumulation

28 Prognosis In the developed world, life expectancy is years, depending on compliance with medical treatment. Untreated individuals with βthalassemiamajor live an average of 17 years and usually die by 30 years of age. Patients transfused with blood screened for viruses and treated with iron chelating agents survive well into the 5th decade The 5year survival of heart failure in patients with thalassemiamajor was similar to that of the regular heart failure populationafter the addition to the regular heart failure treatment of intensified blood transfusions to maintain a sufficiently high hemoglobin level and iron chelation Higgs DR et al. Lancet 2012;379:37383

29 Conclusion Heart disease is the primary determinant of prognosis and survival in βthalassemia. Myocardial iron deposition seems to be the trigger for the development of heart failure in thalassemia major. Iron overload in combination with other factors Iron overload in combination with other factors (inflammatory and immunogenetic) can cause left ventricular systolic dysfunction, dilatation, and failure, whereas iron alone may result in left ventricular diastolic dysfunction with myocardial restriction and subsequent pulmonary hypertension and right ventricular dilatation.

30 Conclusion Assessment of myocardial siderosisand monitoring ofcardiac function combined with red cell transfusion and intensification of ironchelationhave converted a once universally fatal diseaseto a chronic illness Excellent longterm prognosisis expected for children who have been chelatedsince avery young age

A group of inherited disorders characterized by reduced or absent amounts of hemoglobin, the oxygencarrying protein inside the red blood cells.

A group of inherited disorders characterized by reduced or absent amounts of hemoglobin, the oxygencarrying protein inside the red blood cells. Thalassemia A group of inherited disorders characterized by reduced or absent amounts of hemoglobin, the oxygencarrying protein inside the red blood cells. Types of Thallasemia 1) Thalassemia trait 2)

More information

Evaluation of Cardiac Complications in Patients with Thalassemia Major Using Serum Ferritin Levels

Evaluation of Cardiac Complications in Patients with Thalassemia Major Using Serum Ferritin Levels Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijssJuneI/2017/016 Evaluation of Cardiac Complications in Patients with Thalassemia Major Using Serum Ferritin Levels Farideh

More information

Part I. Pathophysiology and management of Thalassemia Intermedia. M. Domenica Cappellini Fondazione IRCCS Policlinico University of Milan

Part I. Pathophysiology and management of Thalassemia Intermedia. M. Domenica Cappellini Fondazione IRCCS Policlinico University of Milan Pathophysiology and management of Thalassemia Intermedia M. Domenica Cappellini Fondazione IRCCS Policlinico University of Milan 4th European Symposium on Rare Anaemias 3rd Bulgarian Symposium on Thalassaemia

More information

THALASSEMIA AND COMPREHENSIVE CARE

THALASSEMIA AND COMPREHENSIVE CARE 1 THALASSEMIA AND COMPREHENSIVE CARE Melanie Kirby MBBS, FRCP (C), Hospital for Sick Children, Toronto Associate Professor of Paediatrics, University of Toronto. Objectives 2 By the end of this presentation,

More information

Topic Page: congestive heart failure

Topic Page: congestive heart failure Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation

More information

Anemia s. Troy Lund MSMS PhD MD

Anemia s. Troy Lund MSMS PhD MD Anemia s Troy Lund MSMS PhD MD lundx072@umn.edu Hemoglobinopathy/Anemia IOM take home points. 1. How do we identify the condtion? Smear, CBC Solubility Test (SCD) 2. How does it present clincally? 3. How

More information

Thalassemia Maria Luz Uy del Rosario, M.D.

Thalassemia Maria Luz Uy del Rosario, M.D. Thalassemia Maria Luz Uy del Rosario, M.D. Philippine Society of Hematology and Blood Transfusion Philippine Society of Pediatric Oncology What is Thalassemia Hereditary Hemoglobin disorder Hemolytic anemia

More information

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for

More information

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations

More information

Presentation, symptoms and signs of heart failure

Presentation, symptoms and signs of heart failure 3 Presentation, symptoms and signs of heart failure What will I learn? In this section you will learn: Who is at risk of heart failure The symptoms of heart failure The signs of heart failure The importance

More information

Dilated Cardiomyopathy in Dogs

Dilated Cardiomyopathy in Dogs Dilated Cardiomyopathy in Dogs (a Type of Heart-Muscle Disease) Basics OVERVIEW The heart of the dog is composed of four chambers; the top two chambers are the left and right atria and the bottom two chambers

More information

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Diastolic Heart Failure Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Disclosures Have spoken for Merck, Sharpe and Dohme Sat on a physician advisory

More information

HFpEF. April 26, 2018

HFpEF. April 26, 2018 HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes

More information

Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death

Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death Presenters: Sabrina Phillips, MD FACC FASE Director, Adult Congenital Heart Disease Services The University of Oklahoma

More information

Right-Sided Congestive Heart Failure Basics

Right-Sided Congestive Heart Failure Basics Right-Sided Congestive Heart Failure Basics OVERVIEW Failure of the right side of the heart to pump blood at a sufficient rate to meet the needs of the body or to prevent blood from pooling within the

More information

Πνευμονική υπέρταση και περικαρδιακή συλλογή. Τρόποι αντιμετώπισης

Πνευμονική υπέρταση και περικαρδιακή συλλογή. Τρόποι αντιμετώπισης Πνευμονική υπέρταση και περικαρδιακή συλλογή. Τρόποι αντιμετώπισης Γεώργιος Λάζαρος Καρδιολόγος, Διευθυντής ΕΣΥ Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν. Αθηνών Pericardial syndromes o Acute

More information

Restrictive Cardiomyopathy in Cats (a Type of Heart-Muscle Disease) Basics

Restrictive Cardiomyopathy in Cats (a Type of Heart-Muscle Disease) Basics Restrictive Cardiomyopathy in Cats (a Type of Heart-Muscle Disease) Basics OVERVIEW The heart of the cat is composed of four chambers; the top two chambers are the left and right atria and the bottom two

More information

HISTORY. Question: How do you interpret the patient s history? CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: 45-year-old man.

HISTORY. Question: How do you interpret the patient s history? CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: 45-year-old man. HISTORY 45-year-old man. CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: His dyspnea began suddenly and has been associated with orthopnea, but no chest pain. For two months he has felt

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart

More information

Heart Failure (HF) Treatment

Heart Failure (HF) Treatment Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and

More information

Χριστίνα Χρυσοχόου Καρδιολόγος Επι,Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών, ΙΓΝΑ

Χριστίνα Χρυσοχόου Καρδιολόγος Επι,Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών, ΙΓΝΑ Χριστίνα Χρυσοχόου Καρδιολόγος Επι,Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών, ΙΓΝΑ Digitalisis a genus of about 20 species of herbaceousperennials, shrubs, and biennialsthat are commonly called foxgloves.

More information

Introduction. Al Kindy Col Med J 2013; Vol. 9 No. 1 P: 36. Al Kindy Col Med J 2013; Vol. 9 No. 1 P:36

Introduction. Al Kindy Col Med J 2013; Vol. 9 No. 1 P: 36. Al Kindy Col Med J 2013; Vol. 9 No. 1 P:36 among beta-thalassemic major patients in ibn al-baladi thalassemia center-baghdad Dr. SuhadJassim Mohammed M.B.Ch.B, F.I.C.M.S(Com.Med.) Dr.FarisH.Al-LamiM.B.Ch.B,M.Sc,Ph.DDr.MousaQasim Hussein M.B.Ch.B,

More information

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains Thalassaemias Thalassemia Thalassemia is an inherited autosomal recessive blood disease. Associated with absence or reduction in a or b globin chains. Reduced synthesis of one of the globin chains can

More information

DISCLOSURES ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION NONE

DISCLOSURES ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION NONE ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION Lori M. Tam, MD Providence Heart Institute DISCLOSURES NONE 1 OUTLINE Systolic vs. Diastolic Heart Failure New

More information

An overview of Thalassaemias and Complications

An overview of Thalassaemias and Complications An overview of Thalassaemias and Complications Haemoglobin Haemoglobin is the most abundant protein in blood, and exists as three main types in normal adults: HbA ( ) - 97% HbA 2 ( ) - 2.5% HbF ( ) - 0.5%

More information

ABOUT OMICS INTERNATIONAL CONFERENCES

ABOUT OMICS INTERNATIONAL CONFERENCES ABOUT OMICS GROUP OMICS Group is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information

More information

Multidisciplinary care. Michael Angastiniotis

Multidisciplinary care. Michael Angastiniotis Multidisciplinary care Michael Angastiniotis Pathopysiology of β-thalassaemia Thalassaemia syndromes are inherited haemoglobin disorders caused by defective and imbalanced globin production Excess free

More information

Preface: Thalassemia Bernard G. Forget

Preface: Thalassemia Bernard G. Forget Thalassemia Preface: Thalassemia Bernard G. Forget xiii Thalassemia: An Overview of 50 Years of Clinical Research 1005 Vijay G. Sankaran and David G. Nathan The thalassemias are attributable to the defective

More information

2

2 1 2 Although the term "cardiomyopathy" could theoretically apply to almost any disease affecting the heart, it is usually reserved for "severe myocardial disease leading to heart failure".cardiomyopathy

More information

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea) Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types

More information

Hemosiderin. Livia Vida 2018

Hemosiderin. Livia Vida 2018 Hemosiderin Livia Vida 2018 Questions Histochemical caracteristics of the different pigments. Exogenous pigments. Hemoglobinogenic pigments. Causes and forms of jaundice. Hemoglobinogenic pigments. Pathological

More information

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF

More information

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Pinpoint & properly assign the appropriate heart failure codes Left- vs. Right-sided Left ventricular failure (LVF) may

More information

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on) Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on) N.Koutsogiannis) Department)of)Cardiology) University)Hospital)of)Patras)! I have no conflicts of interest

More information

Peripartum Cardiomyopathy. Lavanya Rai Manipal

Peripartum Cardiomyopathy. Lavanya Rai Manipal Peripartum Cardiomyopathy Lavanya Rai Manipal Definition - PPCM - Dilated cardiomyopathy of unknown cause resulting in cardiac failure that occurs in the peripartum period in women without any preexisting

More information

The right heart: the Cinderella of heart failure

The right heart: the Cinderella of heart failure The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart

More information

Fetal Anemia 02/13/13. Anjulika Chawla, M.D. Assistant Professor Division of Pediatric Hematology/Oncology

Fetal Anemia 02/13/13. Anjulika Chawla, M.D. Assistant Professor Division of Pediatric Hematology/Oncology Fetal Anemia 02/13/13 Anjulika Chawla, M.D. Assistant Professor Division of Pediatric Hematology/Oncology Objectives Definition of anemia Diagnosis of fetal anemia Normal developmental hematopoiesis Etiology

More information

Non-transfusion-dependent thalassemia (NTDT) Bor-Sheng Ko, M.D. Ph.D. Meng-Yao Lu, M.D. National Taiwan University Hospital

Non-transfusion-dependent thalassemia (NTDT) Bor-Sheng Ko, M.D. Ph.D. Meng-Yao Lu, M.D. National Taiwan University Hospital Non-transfusion-dependent thalassemia (NTDT) Bor-Sheng Ko, M.D. Ph.D. Meng-Yao Lu, M.D. National Taiwan University Hospital Introduction Transfusion dependency in thalassemia Transfusions seldom required

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ID NUMBER: FORM NAME: H F A DATE: 10/01/2015 VERSION: D CONTACT YEAR NUMBER: FORM SEQUENCE NUMBER: General Instructions: The Heart Failure Hospital Record

More information

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing

More information

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG CASE DISCUSSION Dr JAYASREE VEERABOINA 2nd yr PG MS OBG Normal Cardiovascular changes in Pregnancy CARDIAC OUTPUT 5 th wk -- starts 12 wks -- 30-35% 30-32 wks -- 40% During labour -- 50% After delivery

More information

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the

More information

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification Cardiomyopathy John Steuter, MD Bryan Heart Disclosures No Conflicts Cardiomyopathy WHO Classification Anatomy & physiology of the LV 1. Dilated Enlarged Systolic dysfunction 2. Hypertrophic Thickened

More information

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD Imaging in Heart Failure: A Multimodality Approach Thomas Ryan, MD Heart Failure HFrEF HFpEF EF50% Lifetime risk 20% Prevalence 6M Americans Societal costs - $30B 50% 5-year survival 1 Systolic

More information

Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function

Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function Understanding Heart Failure with Preserved LV Systolic Function Eric Ernst, MD Medical Director C.O.R.E. Clinic Objectives Clarify the terminology surrounding right heart failure and diastolic heart failure

More information

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

Atrial Fibrillation and Heart Failure: A Cause or a Consequence Atrial Fibrillation and Heart Failure: A Cause or a Consequence Rajat Deo, MD, MTR Assistant Professor of Medicine Division of Cardiology, Electrophysiology Section University of Pennsylvania November

More information

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response

More information

Squeeze, Squeeze, Squeeze: The Importance of Right Ventricular Function and PH

Squeeze, Squeeze, Squeeze: The Importance of Right Ventricular Function and PH Squeeze, Squeeze, Squeeze: The Importance of Right Ventricular Function and PH Javier Jimenez MD PhD FACC Director, Advanced Heart Failure and Pulmonary Hypertension Miami Cardiac & Vascular Institute

More information

Value of echocardiography in chronic dyspnea

Value of echocardiography in chronic dyspnea Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting

More information

Survival and Disease Complication of Thalassemia Major: Experience of 14 Years at King Abdulaziz University Hospital, Jeddah, KSA

Survival and Disease Complication of Thalassemia Major: Experience of 14 Years at King Abdulaziz University Hospital, Jeddah, KSA JKAU: Med. Sci., Vol. 17 No. 1, pp: 19-28 (2010 A.D. / 1431 A.H.) DOI: 10.4197/Med. 17-1.3 Survival and Disease Complication of Thalassemia Major: Experience of 14 Years at King Abdulaziz University Hospital,

More information

The ACC Heart Failure Guidelines

The ACC Heart Failure Guidelines The ACC Heart Failure Guidelines Fakhr Alayoubi, Msc,R Ph President of SCCP Cardiology Clinical Pharmacist Assistant Professor At King Saud University King Khalid University Hospital Riyadh-KSA 2017 ACC/AHA/HFSA

More information

Congestive Heart Failure

Congestive Heart Failure Sheri Saluga Anatomy and Physiology II March 4, 2010 Congestive Heart Failure Scenario George is in congestive heart failure. Because of his condition, his ankles and feet appear to be swollen and he has

More information

RESTRICTIVE CARDIOMYOPATHY

RESTRICTIVE CARDIOMYOPATHY RESTRICTIVE CARDIOMYOPATHY Restrictive cardiomyopathy (RCM) is a rare form of heart muscle disease that is characterized by restrictive filling of the ventricles. In this disease the contractile function

More information

ΚΑΡΔΙΟΛΟΓΟΣ EUROPEAN ACCREDITATION IN TRANSTHORACIC AND TRANSESOPHAGEAL ECHOCARDIOGRAPHY

ΚΑΡΔΙΟΛΟΓΟΣ EUROPEAN ACCREDITATION IN TRANSTHORACIC AND TRANSESOPHAGEAL ECHOCARDIOGRAPHY 1 ΚΑΡΔΙΟΛΟΓΟΣ EUROPEAN ACCREDITATION IN TRANSTHORACIC AND TRANSESOPHAGEAL ECHOCARDIOGRAPHY 2 Constrictive pericarditis (CP) is characterized by impaired ventricular filling due to a stiffened or noncompliant

More information

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008 Irbesartan (Aprovel) for heart failure with preserved systolic function August 2008 This technology summary is based on information available at the time of research and a limited literature search. It

More information

Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT

Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT Key Messages Heart Failure is Common Heart failure is complex Heart Failure is a major issue for the NHS Heart Failure has a worse prognosis

More information

HEART FAILURE. Study day November 2018 Sarah Briggs

HEART FAILURE. Study day November 2018 Sarah Briggs HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure

More information

Thalassaemia & the heart

Thalassaemia & the heart Thalassaemia & the heart Dr. Malcolm Walker Consultant Cardiologist University College & the National Heart Hospital London Clinical Director Hatter Cardiovascular Institute UCLH JMW 2010 3 rd Pan American

More information

Περικαρδίτιδα στην καρδιακή ανεπάρκεια

Περικαρδίτιδα στην καρδιακή ανεπάρκεια ΣΕΜΙΝΑΡΙΑ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ, ΙΩΑΝΝΙΝΑ 2015 Περικαρδίτιδα στην καρδιακή ανεπάρκεια Γεώργιος Λάζαρος Α Πανεπιστηµιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν. Αθηνών I declare that I have no conflict of interest

More information

Medical Management of Acute Heart Failure

Medical Management of Acute Heart Failure Critical Care Medicine and Trauma Medical Management of Acute Heart Failure Mary O. Gray, MD, FAHA Associate Professor of Medicine University of California, San Francisco Staff Cardiologist and Training

More information

Cardiac Care in pa+ents with Duchenne muscular dystrophy

Cardiac Care in pa+ents with Duchenne muscular dystrophy Cardiac Care in pa+ents with Duchenne muscular dystrophy Linda Cripe, M.D. Professor of Pediatrics The Heart Center.... Why are cardiologists interested in patients with Duchenne muscular dystrophy?....

More information

Diagnosis is it really Heart Failure?

Diagnosis is it really Heart Failure? ESC Congress Munich - 25-29 August 2012 Heart Failure with Preserved Ejection Fraction From Bench to Bedside Diagnosis is it really Heart Failure? Prof. Burkert Pieske Department of Cardiology Med.University

More information

Updates in Congestive Heart Failure

Updates in Congestive Heart Failure Updates in Congestive Heart Failure GREGORY YOST, DO JOHNSTOWN CARDIOVASCULAR ASSOCIATES 1/28/2018 Disclosures Edwards speaker on Sapien3 valves (TAVR) Stages A-D and NYHA Classes I-IV Stage A: High risk

More information

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover

More information

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011 Surgery and device intervention for the elderly with heart failure: assessing the need Devices and Technology for heart failure in 2011 Assessing cardiovascular function / prognosis (in the elderly): composite

More information

2016 Internal Medicine Preferred Specialty Measure Set

2016 Internal Medicine Preferred Specialty Measure Set 1 0059 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period 5 0081 Registry, EHR, 9 0105

More information

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN SICKLE CELL DISEASE Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Objective: The student should be able: To identify the presentation, diagnosis,

More information

Thalassemia. By: Rebecca Chang (Period 6)

Thalassemia. By: Rebecca Chang (Period 6) + Thalassemia By: Rebecca Chang (Period 6) + Physiology Ø Two types of thalassemia: alpha and beta Ø Autosomal recessive inheritance pattern Ø Hemoglobin is damaged but symptoms greatly vary, especially

More information

Pathophysiology: Heart Failure

Pathophysiology: Heart Failure Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions

More information

Dependance on chronic transfusion

Dependance on chronic transfusion Dependance on chronic transfusion Pr Saliou Diop Hematology Blood transfusion Dakar- Sénégal diop@cnts-dakar.sn Introduction Chronic transfusion: Regular use of blood transfusion in patients with chronic

More information

Heart Failure. Dr. William Vosik. January, 2012

Heart Failure. Dr. William Vosik. January, 2012 Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment

More information

Myocarditis in a patient with Campylobacter enteritis

Myocarditis in a patient with Campylobacter enteritis Myocarditis in a patient with Campylobacter enteritis Dries De Cock, M.D. University Hospitals Leuven Department of Cardiology Herestraat 49 3000 Leuven - Belgium DECLARATION OF CONFLICT OF INTEREST No

More information

Heart. Severe. Failure. Congestive heart failure (CHF) is very. What you can do for your patients

Heart. Severe. Failure. Congestive heart failure (CHF) is very. What you can do for your patients Focus on CME at the University of Université Manitoba de Sherbrooke By Anne Fradet, MD, FRCP, CSPQ Severe Heart Failure What you can do for your patients The case of Mr. White Mr. White, 72, comes to your

More information

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder

More information

Dobutamine-induced increase in heart rate is blunted by ivabradine treatment in patients with acutely decompensated heart failure

Dobutamine-induced increase in heart rate is blunted by ivabradine treatment in patients with acutely decompensated heart failure Dobutamine-induced increase in heart rate is blunted by ivabradine treatment in patients with acutely decompensated heart failure Yuksel Cavusoglu, KU Mert, A Nadir, F Mutlu, E Gencer, T Ulus, A Birdane

More information

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling

More information

Heart Failure Clinician Guide JANUARY 2016

Heart Failure Clinician Guide JANUARY 2016 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.

More information

Takotsubo Cardiomyopathy

Takotsubo Cardiomyopathy Advances in Heart Disease 2008 Takotsubo Cardiomyopathy Mary O. Gray, MD, FAHA, FACC Associate Professor of Medicine University of California, San Francisco Staff Cardiologist and Training Faculty Divisions

More information

How far one should go with iron chelation in thalassemia? Is iron deficiency indicated?

How far one should go with iron chelation in thalassemia? Is iron deficiency indicated? How far one should go with iron chelation in thalassemia? Is iron deficiency indicated? DR. KALLISTHENI FARMAKI THALASSAEMIA UNIT GENERAL HOSPITAL OF CORINTH, GREECE VASILI BERDOUKAS PEDIATRIC HEMATOLOGIST

More information

The NEW Heart Failure Guidelines

The NEW Heart Failure Guidelines The NEW Heart Failure Guidelines Daily Practice HF scenario of the Case Presentations HF as a complex and heterogeneous syndrome Several proposed pathophysiological mechanisms involving the heart and the

More information

Cor pulmonale. Dr hamid reza javadi

Cor pulmonale. Dr hamid reza javadi 1 Cor pulmonale Dr hamid reza javadi 2 Definition Cor pulmonale ;pulmonary heart disease; is defined as dilation and hypertrophy of the right ventricle (RV) in response to diseases of the pulmonary vasculature

More information

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure Atrial Fibrillation Ablation in Patients with Heart Failure Eleftherios M. Kallergis, MD, PhD, FESC Cardiology Department, Heraklion University Hospital Since auricular fibrillation so often complicates

More information

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009 Objectives Diastolic Heart Failure and Indications for Echocardiography in the Asian Population Damon M. Kwan, MD UCSF Asian Heart & Vascular Symposium 02.07.09 Define diastolic heart failure and differentiate

More information

Study on Safety and Efficacy of Deferasirox in the treatment of Thalassemia in a South Indian Tertiary Care Hospital

Study on Safety and Efficacy of Deferasirox in the treatment of Thalassemia in a South Indian Tertiary Care Hospital Research Article Study on Safety and Efficacy of Deferasirox in the treatment of Thalassemia in a South Indian Tertiary Care Hospital Siva Shankar Reddy Y *1, Umesh Kamrthi 2 and Balasubramanian Kumar

More information

Is it HF secondary to rheumatic heart disease???

Is it HF secondary to rheumatic heart disease??? Is it HF secondary to rheumatic heart disease??? Is mitral regurg. Is complication of CHF??? Cardiomyopathy Definition The term cardiomyopathy is purely descriptive, meaning disease of the heart muscle

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Pericardial diseases

Pericardial diseases Pericardial diseases Anatomy of the pericardium Consists of parietal and visceral membranes. The space between them(pericardial space is normally filled by a lymph like fluid. The fluid s normal quantity

More information

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 www.ivis.org Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 São Paulo, Brazil - 2009 Next WSAVA Congress : Reprinted in IVIS with the permission of the Congress Organizers MANAGEMENT

More information

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014 HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center March 2014 Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading

More information

Heart.org/HFGuidelinesToolkit

Heart.org/HFGuidelinesToolkit 2017 /H/HFS Focused Update of the 2013 F/H 6.3.1 Biomarkers for Prevention: Recommendation OR LOE Recommendation a For patients at risk of developing HF, natriuretic peptide biomarker-based screening followed

More information

Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore

Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore Journal Club 13 Febbraio 2008 Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore Intissar Sleiman Prevalence of heart failure by sex and age (NHANES:1999-2004) Circulation 2007

More information

Heart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA

Heart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA Heart Failure with Reduced EF Dino Recchia, MD, FACC, FHFSA Heart Failure HF is the end phenotype of almost all CV disorders Complex clinical syndrome resulting from any structural or functional impairment

More information

MD (Res) Thesis University Of London. Sunil Viswanathan Nair

MD (Res) Thesis University Of London. Sunil Viswanathan Nair The Role Of Brain Natriuretic Peptide And Tissue Doppler Echocardiography in the Management of Transfusion Dependent Thalassaemia Patients MD (Res) Thesis University Of London Sunil Viswanathan Nair 1

More information

State-of-the-Art Management of Chronic Systolic Heart Failure

State-of-the-Art Management of Chronic Systolic Heart Failure State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures

More information

ECG Workshop. Nezar Amir

ECG Workshop. Nezar Amir ECG Workshop Nezar Amir Myocardial Ischemia ECG Infarct ECG in STEMI is dynamic & evolving Common causes of ST shift Infarct Localisation Left main artery occlusion: o diffuse ST-depression with ST elevation

More information

The Circulatory System. The circulatory system includes the Heart, Blood Tissue and the Blood Vessels.

The Circulatory System. The circulatory system includes the Heart, Blood Tissue and the Blood Vessels. The Circulatory System The circulatory system includes the Heart, Blood Tissue and the Blood Vessels. The Circulatory System-Transport The absorption and circulation of materials throughout an organism

More information

How to Write a Life Care Plan for a Child with Hemoglobinopathy

How to Write a Life Care Plan for a Child with Hemoglobinopathy How to Write a Life Care Plan for a Child with Hemoglobinopathy Tamar Fleischer, BSN, MSN, CNLCP & Mona Yudkoff, RN, MPH, CRRN, CNLCP BalaCare Solutions March 2018 St. Peterburg, Florida What is Hemoglobinopathy?

More information

UPDATES IN MANAGEMENT OF HF

UPDATES IN MANAGEMENT OF HF UPDATES IN MANAGEMENT OF HF Jennifer R Brown MD, MS Heart Failure Specialist Medstar Cardiology Associates DC ACP Meeting Fall 2017 Disclosures: speaker bureau for novartis speaker bureau for actelion

More information

Ontario s Referral and Listing Criteria for Adult Heart Transplantation

Ontario s Referral and Listing Criteria for Adult Heart Transplantation Ontario s Referral and Listing Criteria for Adult Heart Transplantation Version 3.0 Trillium Gift of Life Network Adult Heart Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The

More information